Fig. 3From: Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experiencePFS (a) and OS (b) of patients receiving nal-IRI + 5-FU/LV based on treatment sequence. Patients were classified based on common treatment sequences utilizedBack to article page